InfuSystem Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $143.3M+6.3% YoYTTM through 30 Jun 2026
Net Income $8.5M+264.3% YoYTTM through 30 Jun 2026
Free Cash Flow $22.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 58.4% |
| EBITDA Margin | 18.4% |
| Operating Margin | 4.8% |
| Net Margin | 6.0% |
Returns
13.5%ROE
8.0%ROA
10.2%ROIC
Balance Sheet Health
Debt / Equity0.33x
Current Ratio2.14x
Net Debt$17.5M
Cash & Equivalents$964K
Quality Metrics
Altman Z-Score5.44
Piotroski F-Score8 / 9
FCF Margin16.0%
Rule of 4017.0
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $143.4M
Diluted EPS$0.40TTMFY2025: $0.31
Dividend
No dividend
Capital Allocation
Capex Intensity0.3%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.